• Return to Headlines

Recent 52-Week High Exceeded in Shares of Neogenomics Inc (NEO)

By James Quinn

Shares of Neogenomics Inc (NASDAQ:NEO) traded at a new 52-week high today of $10.34. This new high was reached on below average trading volume as 118,000 shares traded hands, while the average 30-day volume is approximately 347,000 shares.

NeoGenomics, Inc. operates a network of clinical laboratories that specializes in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.

Over the past year, Neogenomics Inc has traded in a range of $6.90 to $10.34 and is now at $10.14, 47% above that low. Over the past week, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 2.4%.

Neogenomics Inc (NASDAQ:NEO) has potential upside of 9.1% based on a current price of $10.14 and analysts' consensus price target of $11.06. The stock should discover initial support at its 50-day moving average (MA) of $6.97 and subsequent support at its 200-day MA of $6.82.

SmarTrend recommended that subscribers consider buying shares of Neogenomics Inc on June 12th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $8.23. Since that recommendation, shares of Neogenomics Inc have risen 25.1%. We continue to monitor NEO for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows neogenomics inc

Ticker(s): NEO